The relationship between anti‐cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis

References

• Kvien T. K. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004; 2((Suppl 22))1–12
   Google Scholar
• Spector T. D., Hall G. M., McCloskey E. V., Kanis J. A. Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 1993; 306: 558
   PubMed Web of Science ®Google Scholar
• Rehman Q., Lane N. E. Bone loss: therapeutic approaches for preventing bone loss in inflammatory arthritis. Arthritis Res 2001; 3: 221–7
   PubMedGoogle Scholar
• Momohara S., Okamoto H., Yago T., Furuya T., Nanke Y., Kotake S., et al. The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis. Mod Rheumatol 2005; 15: 410–14
   PubMedGoogle Scholar
• Jensen T., Hansen M., Madsen J. C., Kollerup G., Stoltenberg M., Florescu A., et al. Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment. Scand J Clin Lab Invest 2001; 61: 491–501
   PubMed Web of Science ®Google Scholar
• Schellekens G. A., Visser H., de Jong B. A., van den Hoogen F. H., Hazes J. M., Breedveld F. C., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155–63
   PubMed Web of Science ®Google Scholar
• Rantapaa‐Dahlqvist S. Diagnostic and prognostic significance of autoantibodies in early rheumatoid arthritis. Scand J Rheumatol 2005; 34: 83–96
   PubMed Web of Science ®Google Scholar
• Kwok J. S., Hui K. H., Lee T. L., Wong W., Lau Y. L., Wong R. W., et al. Anti‐cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand J Rheumatol 2005; 34: 359–66
   PubMed Web of Science ®Google Scholar
• Vossenaar E. R., Zendman A. J., Van Venrooij W. J. Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis. Arthritis Res Ther 2004; 6: 1–5
   PubMedGoogle Scholar
• Nikolaisen C., Rekvig O. P., Nossent H. C. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis. Scand J Rheumatol 2007; 36: 97–100
   PubMed Web of Science ®Google Scholar
• Kroot E. J., de Jong B. A., van Leeuwen M. A., Swinkels H., van den Hoogen F. H., van't Hof M., et al. The prognostic value of anti‐cyclic citrullinated peptide antibody in patients with recent‐onset rheumatoid arthritis. Arthritis Rheum 2000; 43: 1831–5
   PubMed Web of Science ®Google Scholar
• Goldbach‐Mansky R., Lee J., McCoy A., Hoxworth J., Yarboro C., Smolen J. S., et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2: 236–43
   PubMedGoogle Scholar
• Bizzaro N., Mazzanti G., Tonutti E., Villalta D., Tozzoli R. Diagnostic accuracy of the anti‐citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001; 47: 1089–93
   PubMed Web of Science ®Google Scholar
• Bas S., Perneger T. V., Seitz M., Tiercy J. M., Roux‐Lombard P., Guerne P. A. Diagnostic tests for rheumatoid arthritis: comparison of anti‐cyclic citrullinated peptide antibodies, anti‐keratin antibodies and IgM rheumatoid factors. Rheumatology 2002; 41: 809–14
   PubMed Web of Science ®Google Scholar
• van Jaarsveld C. H., ter Borg E. J., Jacobs J. W., Schellekens G. A., Gmelig‐Meyling F. H., van Booma‐Frankfort C., et al. The prognostic value of the antiperinuclear factor, anti‐citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 1999; 17: 689–97
   PubMed Web of Science ®Google Scholar
• Meyer O., Labarre C., Dougados M., Goupile Ph., Cantagrel A., Dubois A., et al. Anti‐citrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five‐year radiographic damage. Ann Rheum Dis 2003; 62: 120–6
   PubMed Web of Science ®Google Scholar
• van der Heide A., Remme C. A., Hofman D. M., Jacobs J. W. G., Bijlsma J. W. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis. Arthritis Rheum 1995; 38: 1466–74
   PubMed Web of Science ®Google Scholar
• O'Dell J. R. Rheumatoid arthritis: the clinical picture. Arthritis and allied conditions: a textbook of rheumatology, vol. 1, W. J Koopman, L. W Moreland. Lippincott Williams & Wilkins, Philadelphia 2005; 1165–94
   Google Scholar
• Bongi S. M., Manetti R., Melchiorre D., Turchini S., Boccaccini P., Vanni L., et al. Anti‐cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti‐CCP and bone damage in RA. Autoimmunity 2004; 37: 495–501
   PubMedGoogle Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., Meshane D. J., Fries J. F., Cooper N. S. The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Sharp J. T., Lidsky M. D., Collins L. C., Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971; 14: 706–20
   PubMed Web of Science ®Google Scholar
• Sharp J. T., Young D. Y., Bluhm G. B., Brook A., Brower A. C., Corbett M., et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?. Arthritis Rheum 1985; 28: 1326–35
   PubMed Web of Science ®Google Scholar
• van Gestel A. M., Haagsma C. J., van Riel P. L. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 1845–50
   PubMed Web of Science ®Google Scholar
• Carson D. A., Chen P. P., Fox R. I., Kipps T. J., Jirik F., Goldfien R. D., et al. Rheumatoid factor and immune networks. Annu Rev Immunol 1987; 5: 109–26
   PubMed Web of Science ®Google Scholar
• Agrawal S., Misra R., Aggarwal A. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA. Clin Rheumatol 2007; 26: 201–4
   PubMed Web of Science ®Google Scholar
• Glasnovic M., Bosnjak I., Vcev A., Soldo I., Glasnovic‐Horvatic E., Soldo‐Butkovic S., et al. Anti‐citrullinated antibodies, radiological joint damages and their correlations with disease activity score (DAS 28). Coll Antropol 2007; 31: 345–8
   PubMedGoogle Scholar
• Shovman O., Gilburd B., Zandman‐Goddard G., Sherer Y., Orbach H., Gerli R., et al. The diagnostic utility of anti‐cyclic citrullinated peptide antibodies, matrix metalloproteinase‐3, rheumatoid factor, erythrocyte sedimentation rate, and C‐reactive protein in patients with erosive and non‐erosive rheumatoid arthritis. Clin Dev Immunol 2005; 12: 197–202
   PubMedGoogle Scholar
• del Val del Amo N., Ibanez Bosch R., Fito Manteca C., Gutierrez Polo R., Loza Cortina E. Anti‐cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness. Clin Exp Rheumatol 2006; 24: 281–6
   PubMed Web of Science ®Google Scholar
• Mewar D., Coote A., Moore D. J., Marinou I., Keyworth J., Dickson M. C., et al. Independent association of anti‐cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis. Arthritis Res Ther 2006; 8: R128
   PubMed Web of Science ®Google Scholar
• Forslind K., Ahlmen M., Eberhardt K., Hafström I., Svensson B. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti‐CCP). Ann Rheum Dis 2004; 63: 1090–5
   PubMed Web of Science ®Google Scholar
• Berglin E., Johansson T., Sundin U., Jidell E., Wadell G., Hallmans G., et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA‐RF at disease onset. Ann Rheum Dis 2006; 65: 453–8
   PubMed Web of Science ®Google Scholar
• Machold K. P., Stamm T. A., Nell V. P., Pflugbeil D., Aletaha D., Steiner G., et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology 2007; 46: 342–9
   PubMed Web of Science ®Google Scholar
• Forslind K., Vincent C., Serre G., Svensson B. Antifilaggrin antibodies in early rheumatoid arthritis may predict radiological progression. Scand J Rheumatol 2001; 30: 221–4
   PubMedGoogle Scholar
• Sinigaglia R., Nervetti A., Mela Q., Bianchi G., Del Puente A., Di Munno O., et al. A multicenter cross‐sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000; 27: 2582–9
   PubMed Web of Science ®Google Scholar
• Forsblad D'Elia H., Larsen A., Waltbrand E., Kvist G., Mellstrom D., Saxne T., et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 2003; 62: 617–23
   PubMed Web of Science ®Google Scholar
• Oelzner P., Müller A., Deschner F., Hüller M., Abendroth K., Hein G., et al. Relationship between disease activity and serum levels of vitamin D metabolites and PTH in rheumatoid arthritis. Calcif Tissue Int 1998; 62: 193–8
   PubMed Web of Science ®Google Scholar
• Kastbom A., Strandberg G., Lindroos A., Skogh T. Anti‐CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA Project). Ann Rheum Dis 2004; 63: 1085–9
   PubMed Web of Science ®Google Scholar
• Vencovsky J., Machacek S., Sedova L., Kafkova J., Gatterova J., Pesakova V., et al. Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis 2003; 62: 427–30
   PubMed Web of Science ®Google Scholar
• van der Helm‐van Mil A. H., Verpoort K. N., Breedveld F. C., Toes R. E., Huizinga T. W. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005; 7: R949–58
   PubMed Web of Science ®Google Scholar